Skip to content

Gross margin at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
67.8%-0.5pp
Stryker logo
StrykerSYK
63.8%-0.1pp
CONMED logo
CONMEDCNMD
55.2%-1.0pp
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
70%-1.0pp
Enovis logo
EnovisENOV
60.5%+4.0pp
OrthoPediatrics logo
OrthoPediatricsKIDS
73.1%+0.3pp

Other financials

Income statement

See full
Revenue$47.2M-10.2%
Gross profit$37.4M-10.7%
Operating income-$17.2M-10.2%
Net income-$18.0M-12.8%
EPS (diluted)-$0.28-12.0%

Balance sheet

See full
Cash & equivalents$9.5M-28.6%
Total debt$71.6M+3.2%
Total equity$77.2M-26.7%
Total assets$184.1M-10.6%

Cash flow

See full
Operating cash flow$7.2M+72.5%
CapEx$3.1M-13.6%
Free cash flow$4.2M+538%

Valuation

See full
Market cap$258.19M-26.6%
Enterprise value$320.25M-22.6%
P/S1.3×-0.4×

Profitability

See full
Operating margin-26.9%+2.5pp
Net margin-29.4%+6.1pp
FCF margin-12.5%-2.8pp

Returns & leverage

See full
Return on equity-66.9%+57.5pp
Debt / equity0.9×+0.3×
Current ratio3.6×-0.9×

Where this comes from

Calculated from Treace Medical Concepts, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Treace Medical Concepts, Inc.'s gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Treace Medical Concepts, Inc.'s gross margin?
Treace Medical Concepts, Inc. (TMCI) reported gross margin of 79.7% in Q1 2026.
How has Treace Medical Concepts, Inc.'s gross margin changed year-over-year?
Treace Medical Concepts, Inc.'s gross margin decreased by 0.7% year-over-year, from 80.2% to 79.7%.
What is the long-term trend for Treace Medical Concepts, Inc.'s gross margin?
Over 5 years (2020 to 2025), Treace Medical Concepts, Inc.'s gross margin has grown at a 0.4% compound annual growth rate (CAGR), from 78.3% to 79.8%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.